Found: 28
Select item for more details and to access through your institution.
Treosulphan versus busulphan: pros and cons.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 304, doi. 10.1111/bjh.17816
- By:
- Publication type:
- Article
The use of genetic tests to diagnose and manage patients with myeloproliferative and myeloproliferative/myelodysplastic neoplasms, and related disorders.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 338, doi. 10.1111/bjh.17766
- By:
- Publication type:
- Article
Does eventually NPM1 mutation in blast phase chronic myeloid leukemia (BP‐CML) exist? That is the question.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 469, doi. 10.1111/bjh.17761
- By:
- Publication type:
- Article
Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinib.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 466, doi. 10.1111/bjh.17759
- By:
- Publication type:
- Article
Allogeneic hematopoietic cell transplantation in patients with myelodysplastic syndrome using treosulfan based compared to other reduced‐intensity or myeloablative conditioning regimens. A report of the chronic malignancies working party of the EBMT
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 417, doi. 10.1111/bjh.17817
- By:
- Publication type:
- Article
Is it the therapy or the disease? Exploring the link between treatment for immune thrombocytopenia and thrombosis.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 308, doi. 10.1111/bjh.17745
- Publication type:
- Article
Omacetaxine added to a standard acute myeloid leukaemia chemotherapy regimen reduces cellular FLIP levels, markedly increasing the incidence of eccrine hidradenitis.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. e138, doi. 10.1111/bjh.17715
- By:
- Publication type:
- Article
The impact of bridging therapy prior to CD19‐directed chimeric antigen receptor T‐cell therapy in patients with large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 405, doi. 10.1111/bjh.17738
- By:
- Publication type:
- Article
Beyond ruxolitinib in steroid‐refractory acute graft‐versus‐host disease.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 306, doi. 10.1111/bjh.17735
- By:
- Publication type:
- Article
MiR‐22, a serum predictor of poor outcome and therapy response in diffuse large B‐cell lymphoma patients.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 399, doi. 10.1111/bjh.17734
- By:
- Publication type:
- Article
Donor‐derived gene mutations in sex chromosome loss after stem cell transplantation.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. e142, doi. 10.1111/bjh.17716
- By:
- Publication type:
- Article
De novo isolated myeloid sarcoma: comparative analysis of survival in 19 consecutive cases.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 413, doi. 10.1111/bjh.17742
- By:
- Publication type:
- Article
Graham Serjeant, Sickle Cell, Jamaica and Beyond: A Life, Ian Randle Publishers (Kingston and Miami), 2021.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 472, doi. 10.1111/bjh.17686
- Publication type:
- Article
Earlier corticosteroid use for adverse event management in patients receiving axicabtagene ciloleucel for large B‐cell lymphoma.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 388, doi. 10.1111/bjh.17673
- By:
- Publication type:
- Article
Expanding the immune armoury against myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 301, doi. 10.1111/bjh.17711
- By:
- Publication type:
- Article
Exacerbation of immune thrombocytopenia following COVID‐19 vaccination.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 365, doi. 10.1111/bjh.17645
- Publication type:
- Article
Pseudo‐Chédiak–Higashi inclusions in relapsed acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 300, doi. 10.1111/bjh.17635
- By:
- Publication type:
- Article
The management of Castleman disease.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 328, doi. 10.1111/bjh.17688
- By:
- Publication type:
- Article
Risk factors of hospitalisation for thrombosis in adults with primary immune thrombocytopenia, including disease‐specific treatments: a French nationwide cohort study.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 456, doi. 10.1111/bjh.17709
- By:
- Publication type:
- Article
COVID‐19 elicits an impaired antibody response against SARS‐CoV‐2 in patients with haematological malignancies.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 371, doi. 10.1111/bjh.17704
- By:
- Publication type:
- Article
Ruxolitinib resistance or intolerance in steroid‐refractory acute graft‐versus‐host disease — a real‐world outcomes analysis.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 429, doi. 10.1111/bjh.17700
- By:
- Publication type:
- Article
Phase II study of azacitidine with pembrolizumab in patients with intermediate‐1 or higher‐risk myelodysplastic syndrome.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 378, doi. 10.1111/bjh.17689
- By:
- Publication type:
- Article
Management of a patient with a rare congenital limb malformation syndrome after SARS‐CoV‐2 vaccine‐induced thrombosis and thrombocytopenia (VITT).
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 299, doi. 10.1111/bjh.17619
- By:
- Publication type:
- Article
Which adults with sickle cell disease need an evaluation for pulmonary embolism?
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 447, doi. 10.1111/bjh.17552
- By:
- Publication type:
- Article
DNA and modified vaccinia Ankara prime–boost vaccination generates strong CD8<sup>+</sup> T cell responses against minor histocompatibility antigen HA‐1.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 433, doi. 10.1111/bjh.17495
- By:
- Publication type:
- Article
How we treat advanced stage cutaneous T‐cell lymphoma – mycosis fungoides and Sézary syndrome.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 352, doi. 10.1111/bjh.17458
- By:
- Publication type:
- Article
Peripheral blood molecular measurable residual disease is sufficient to identify patients with acute myeloid leukaemia with imminent clinical relapse.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 310, doi. 10.1111/bjh.17449
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- British Journal of Haematology, 2021, v. 195, n. 3, p. 295, doi. 10.1111/bjh.16841
- Publication type:
- Article